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Renal Sympathetic DenervationWe appreciate the insightful comments of Drs. Ormezzano
and Baguet on our paper (1). In our proof-of-concept study,
we demonstrated for the ﬁrst time that impaired spontaneous
cardiac baroreﬂex sensitivity (BRS) might be a valuable tool for
identiﬁcation of patients with hypertension who might beneﬁt
from renal sympathetic denervation (RDN). It is correct that
we assessed BRS in 2 ways, namely, by phase-rectiﬁed signal
averaging (PRSA; BRSPRSA) and by the sequence method
(BRSSEQ). It is also correct that the prognostic value of
BRSPRSA in predicting response to RDN was superior to that
of BRSSEQ. However, our study was neither powered nor
intended to compare the predictive values of different BRS
measures. According to our pre-speciﬁed hypothesis, we deﬁned
BRSPRSA as the primary variable, which was therefore tested in
multivariate models. Importantly, we did not show that RDN led
to restoration of impaired BRS as mentioned by Drs. Ormezzano
and Baguet. This interesting hypothesis will be tested in up-
coming projects.
The assessment of BRS by PRSA is conceptually new and
differs from previous approaches to BRS assessment in many
aspects. PRSA is a comprehensive signal processing technology
that is capable of extracting periodic patterns out of complex
biological signals such as recordings of heart rate, blood pressure,
and respiratory activity (2,3). An extension of the PRSA tech-
nology allows the analysis of coupled periodic patterns in simul-
taneously recorded biosignals, which is of obvious advantage in
assessment of spontaneous BRS (4,5). We agree that the prog-
nostic value of a BRS measure is of great importance. The
prognostic value of BRSPRSA has been prospectively validated in
941 surviving patients with acute myocardial infarction, for which
it proved to be superior to that of BRSSEQ and other techniques in
prediction of 5-year all-cause mortality (6). We acknowledge the
promising results of BRSSEQ as a risk predictor in patients with
hypertension in the EVABAR (Evaluation of the Prognostic
Value of Baroreﬂex Sensitivity in Hypertensive Patients) study.
Therefore, we would like to suggest that Drs. Ormezzano and
Baguet conduct a blinded analysis of BRSPRSA in patients of the
EVABAR study.Christine S. Zuern, MD
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Magnetic Resonance
Imaging in the Assessment
of Left Atrial Function
We read with great interest the review article by Hoit (1), in which
most of the available articles about the role of left atrial (LA)
function and size in different cardiovascular diseases have been
reviewed. As mentioned, analyzing LA function has always been
challenging, given the distance of the LA from the chest wall and
its thin asymmetrical wall. The presence of pulmonary veins and
left atrial appendage also makes it more challenging to evaluate LA
function than left ventricular function. On the other hand, cardiac
magnetic resonance imaging (CMRI) has been proposed as the
gold standard method for the assessment of LA volume. However,
as the author mentioned, inability to measure phasic volumes had
been a major limitation of CMRI.
Feature tracking (or tissue tracking) CMRI is a new technique
in the assessment of myocardial wall motion and measurement
of heart chamber volumes. This is a novel post-processing
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2435technique that tracks the myocardial wall by using cine CMR
images. With feature/tissue tracking CMRI, phasic LA volume,
LA strain and strain rate, and LA velocity can be measured using
cine images. In a recent study performed with 28 patients with
atrial ﬁbrillation, feature-tracking MRI was able to detect changes
in LA strain, strain rate, and velocity following catheter ablation
(2). Preliminary studies within the Multi-Ethnic Study of Ath-
erosclerosis have shown the usefulness of tissue-tracking–derived
LA strain and strain rate in patients with atrial ﬁbrillation (3),
heart failure (4), and myocardial infarction (5).
The results of studies of reproducibility and repeatability of feature-/
tissue-tracking methods of MRI have been mixed (6,7). Moreover,
studies of LA structure and function from feature-/tissue-tracking
CMRI speciﬁcally have been lacking. Although further technical im-
provements and more studies are required before feature-/tissue-
tracking MRI can be used routinely, it is, nevertheless, a valuable tool
for detailed assessment of phasic LA structure and function.*Mohammadali Habibi, MD
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Magnetic Resonance
Imaging in the Assessment
of Left Atrial FunctionI appreciate the interest shown by Dr. Habibi and colleagues,
and thank them for their recent contributions to the ﬁeld of left
atrial (LA) function, which as they imply, were neglected in myState-of-the Art review (2). Calibrating the completeness of these
reviews can be problematic and requires balancing the novelty of a
method with its demonstrated validity and clinical utility. Tissue-
tracking cardiac magnetic resonance (FT-CMR) is a new and
potentially useful technique for measuring strain from routine cine
CMR images using feature-tracking algorithms that were initially
designed for echocardiographic strain analysis. FT-CMR tracks
motion of a tissue voxel using standard steady-state free precession
sequences and is simpler, more practical and available, and less time
consuming than other CMR-based strain techniques. However, as
Dr. Habibi and colleagues state in their letter, reproducibility and
repeatability data for FT-CMR ventricular strain measurements are
conﬂicting (1). More recently, in a study of 145 healthy volunteers,
global circumferential but not longitudinal strain showed reason-
able agreement with tagged CMR, with acceptable interobserver
reproducibility (2). In another study, there was considerable vari-
ability between FT-CMR and two-dimensional speckle tracking
echo strains of the right ventricle (RV) and left ventricle (LV) in
20 patients with tetralogy of Fallot and 20 control patients (3).
Importantly, reproducibility, variability, and validation data for
atrial FT-CMR (longitudinal) strain are nonexistent.
Moreover, there are no peer-reviewed studies of FT-CMR atrial
strain measurement. Indeed, the studies cited by Dr. Habibi and
colleagues are abstracts that have not, to date, undergone a rigor-
ous review process. Those studies concluded that addition of
FT-CMR LA strain helps distinguish subjects with atrial ﬁbrilla-
tion from controls; that FT-CMR peak systolic atrial strain, but
not LA volumes or emptying fraction, was associated with heart
failure after adjusting for NT-proBNP (N terminal pro brain
natriuretic peptide), traditional heart failure risk factors, and LV
mass; and that FT-CMR peak systolic LA strain and diastolic
strain rate are associated with signiﬁcant late gadolinium LV
myocardial scars (1). The FT-CMR ﬁeld is indisputably
inchoate; acquisition technique, cine sequence, ﬁeld strength, and
temporal resolution are variables that are likely to affect the accu-
racy and precision of FT-CMR measurements of atrial strain
using CMR. The need for further pre-clinical analysis in addi-
tion to clinical trials was trumpeted in a recent editorial (4).
Finally, the focus of my review was the role of LA function in
prognosis. Although it is tempting to extrapolate from the expe-
rience of echocardiographic LA strain, there are no studies of FT-
CMR LA strain that examine outcomes or that compare LA
strain measured with that of FT-CMR to echocardiography.*Brian D. Hoit, MD
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